Carticept Medical, Inc., located in Alpharetta, Georgia, was founded in 2005 by a group of medical device industry veterans.
Carticept, a private, venture capital-backed company, has developed a platform technology to improve the safety,
efficiency and accuracy of many common injection procedures.
Intra-articular steroids have been an important therapy for the management of musculoskeletal disease for more than
50 years and are the standard of care for the early treatment of patients with osteoarthritis. In the United States alone,
there are more than 35 million annual injections into joints to relieve pain and improve mobility. Carticept has developed
the Navigator Delivery System, the first and only FDA-cleared computer controlled medication delivery system for
intra-articular injections. The Navigator DS was specifically designed to enhance patient safety and comfort, while
improving office workflow, facilitating regulatory compliance and improving financial performance.
We are pursuing other indications for the Navigator, such as its use in anesthesia and pain management.
Our management team and board of directors are comprised of industry-recognized professionals who possess broad
knowledge in orthopedics and extensive experience managing innovative medical devices from development through
clinical trials, FDA approval and successful commercialization.